Dipòsit Digital de Documents de la UAB 35 registres trobats  1 - 10següentfinal  anar al registre: La cerca s'ha fet en 0.01 segons. 
1.
14 p, 3.7 MB Cross-regional view of functional and taxonomic microbiota composition in obesity and post-obesity treatment shows country specific microbial contribution / Medina, D.A. (Laboratorio de Biotecnología Aplicada. Facultad de Medicina Veterinaria. Universidad San Sebastián) ; Li, Tianlu (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Thomson, P. (Departamento de Ingeniería Química y Bioprocesos. Escuela de Ingeniería. Pontificia Universidad Católica de Chile) ; Artacho, A. (Genomics and Health Area. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO)-Salud Pública) ; Pérez-Brocal, V. (Genomics and Health Area. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (FISABIO)-Salud Pública) ; Moya, A. (Biomedical Research Centre Network for Epidemiology and Public Health (CIBEResp)) ; Universitat Autònoma de Barcelona
Gut microbiota has been shown to have an important influence on host health. The microbial composition of the human gut microbiota is modulated by diet and other lifestyle habits and it has been reported that microbial diversity is altered in obese people. [...]
2019 - 10.3389/fmicb.2019.02346
Frontiers in microbiology, Vol. 10 Núm. OCT (2019) , p. 2346  
2.
14 p, 2.1 MB kernInt : A Kernel Framework for Integrating Supervised and Unsupervised Analyses in Spatio-Temporal Metagenomic Datasets / Ramon, Elies (Centre de Recerca en Agrigenòmica) ; Belanche-Muñoz, Lluís (Universitat Politècnica de Catalunya. Departament d'Informàtica) ; Molist, Francesc (Schothorst Feed Research) ; Quintanilla, Raquel (Institut de Recerca i Tecnologia Agroalimentàries) ; Perez-Enciso, Miguel (Centre de Recerca en Agrigenòmica) ; Ramayo-Caldas, Yuliaxis (Institut de Recerca i Tecnologia Agroalimentàries)
The advent of next-generation sequencing technologies allowed relative quantification of microbiome communities and their spatial and temporal variation. In recent years, supervised learning (i. e. , prediction of a phenotype of interest) from taxonomic abundances has become increasingly common in the microbiome field. [...]
2021 - 10.3389/fmicb.2021.609048
Frontiers in microbiology, Vol. 12 (January 2021) , art. 609048  
3.
11 p, 2.1 MB mcr -Colistin Resistance Genes Mobilized by IncX4, IncHI2, and IncI2 Plasmids in Escherichia coli of Pigs and White Stork in Spain / Migura-Garcia, Lourdes (Universitat Autònoma de Barcelona. Centre de Recerca en Sanitat Animal) ; González-López, Juan J. (Hospital Universitari Vall d'Hebron) ; Martinez-Urtaza, Jaime (Centre for Environment, Fisheries and Aquaculture Science (CEFAS)) ; Aguirre Sánchez, J. R. (Health and Biotechnology (SaBio) Group, Instituto de Investigación en Recursos Cinégéticos IREC (CSIC-UCLM-JCCM)) ; Moreno-Mingorance, A. (Hospital Universitari Vall d'Hebron) ; Perez de Rozas, A. (Universitat Autònoma de Barcelona. Centre de Recerca en Sanitat Animal) ; Höfle, Ursula (Health and Biotechnology (SaBio) Group, Instituto de Investigación en Recursos Cinégéticos IREC (CSIC-UCLM-JCCM)) ; Ramiro, Y. (Health and Biotechnology (SaBio) Group, Instituto de Investigación en Recursos Cinégéticos IREC (CSIC-UCLM-JCCM)) ; Gonzalez-Escalona, Narjol (Food and Drug Administration)
Colistin has become the last-line antimicrobial for the treatment of multidrug resistant (MDR) Enterobacterales in human medicine. To date, several colistin resistance genes have been described. Of them mcr -1 is disseminated worldwide in Escherichia coli of human and animal origin. [...]
2020 - 10.3389/fmicb.2019.03072
Frontiers in microbiology, Vol. 10 (january 2020)  
4.
3 p, 161.8 KB Editorial : protein solubility and aggregation in bacteria / Ventura, Salvador (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular
The Editorial on the research topic protein solubility and aggregation in bacteria.
2016 - 10.3389/fmicb.2016.01178
Frontiers in microbiology, Vol. 7 (July 2016) , art. 1178  
5.
10 p, 1.4 MB Heterogeneous colistin-resistance phenotypes coexisting in stenotrophomonas maltophiliaisolates influence colistin susceptibility testing / Martínez-Servat, Sònia (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Yero Corona, Daniel (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Huedo Moreno, Pol (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Marquez, Roser (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Molina, Gara (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Daura i Ribera, Xavier (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Gibert, Isidre (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia)
The polymyxin antibiotic colistin shows in vitro activity against Stenotrophomonas maltophilia. However, an increased incidence of colistin-resistant isolates has been recently observed. In addition, in vitro evaluation of colistin susceptibility for this organism has been problematic. [...]
2018 - 10.3389/fmicb.2018.02871
Frontiers in microbiology, Vol. 9 (Nov. 2018) , art. 2871  
6.
13 p, 5.2 MB Discovering putative prion-like proteins in Plasmodium falciparum : a computational and experimental analysis / Pallarès i Goitiz, Irantzu (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Sánchez de Groot, Natalia (Centre de Regulació Genòmica) ; Iglesias, Valentin (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Sant'Anna, Ricardo (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Biosca, Arnau (Institut de Bioenginyeria de Catalunya) ; Fernàndez Busquets, Xavier (Institut de Bioenginyeria de Catalunya) ; Ventura, Salvador (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Prions are a singular subset of proteins able to switch between a soluble conformation and a self-perpetuating amyloid state. Traditionally associated with neurodegenerative diseases, increasing evidence indicates that organisms exploit prion-like mechanisms for beneficial purposes. [...]
2018 - 10.3389/fmicb.2018.01737
Frontiers in microbiology, Vol. 9 (Aug. 2018) , art. 1737  
7.
12 p, 1.6 MB The rho termination factor of Clostridium botulinum contains a prion-like domain with a highly amyloidogenic core / Pallarès i Goitiz, Irantzu (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Iglesias, Valentin (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Ventura, Salvador (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Prion-like proteins can switch between a soluble intrinsically disordered conformation and a highly ordered amyloid assembly. This conformational promiscuity is encoded in specific sequence regions, known as prion domains (PrDs). [...]
2016 - 10.3389/fmicb.2015.01516
Frontiers in microbiology, Vol. 6 (Jan. 2016) , art. 1516  
8.
13 p, 7.9 MB Computational analysis of candidate prion-like proteins in bacteria and their role / Iglesias, Valentin (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Sánchez de Groot, Natalia (Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Ventura, Salvador (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Prion proteins were initially associated with diseases such as Creutzfeldt Jakob and transmissible spongiform encephalopathies. However, deeper research revealed them as versatile tools, exploited by the cells to execute fascinating functions, acting as epigenetic elements or building membrane free compartments in eukaryotes. [...]
2015 - 10.3389/fmicb.2015.01123
Frontiers in microbiology, Vol. 6 (Oct. 2015) , art. 1123  
9.
13 p, 4.9 MB Earlier initiation of antiretroviral treatment coincides with an initial control of the HIV-1 sub-subtype F1 outbreak among men-having-sex-with-men in Flanders, Belgium / Vinken, L. (Laboratory of Clinical and Epidemiological Virology. Department of Microbiology and Immunology. Rega Institute for Medical Research. KU Leuven) ; Fransen, K. (AIDS Reference Laboratory. Department of Clinical Sciences. Institute of Tropical Medicine Antwerp) ; Cuypers, L. (Laboratory of Clinical and Epidemiological Virology. Department of Microbiology and Immunology. Rega Institute for Medical Research. KU Leuven) ; Alexiev, I. (National Reference Confirmatory Laboratory of HIV. National Center of Infectious and Parasitic Diseases) ; Balotta, C. (Infectious Diseases and Immunopathology Section. 'L. Sacco' Department of Biomedical and Clinical Sciences. 'L. Sacco' Hospital. University of Milan) ; Debaisieux, L. (AIDS Reference Laboratory. CUB-Hopital Erasme. Université Libre de Bruxelles) ; Seguin-Devaux, C. (Laboratory of Retrovirology. Department of Infection and Immunity. Luxembourg Institute of Health) ; Ribas, S.G. (AIDS Reference Laboratory. Department of Clinical Sciences. Institute of Tropical Medicine Antwerp) ; Gomes, P. (Centro de Investigação Interdisciplinar Egas Moniz. Instituto Universitário Egas Moniz) ; Incardona, F. (EuResist Network GEIE) ; Kaiser, R. (Institute of Virology. University of Cologne) ; Ruelle, J. (Unit of Medical Microbiology. Institute of Experimental and Clinical Research. Université Catholique de Louvain) ; Sayan, M. (Research Center of Experimental Health Sciences. Near East University) ; Paraschiv, S. (Molecular Diagnostics Laboratory. National Institute for Infectious Diseases 'Matei Bals') ; Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Peeters, M. (UMI 233 TransVIHMI/INSERM1175. Institut de Recherche pour le Développement. University of Montpellier) ; Sönnerborg, A. (Division of Clinical Microbiology. Department of Laboratory Medicine. Karolinska Institutet) ; Vancutsem, E. (AIDS Reference Laboratory. Department of Microbiology and Infection Control. Universitair Ziekenhuis Brussel) ; Vandamme, A.M. (Unidade de Microbiologia. Center for Global Health and Tropical Medicine. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa) ; Van den Wijngaert, S. (AIDS Reference Laboratory. Department of Microbiology. Saint-Pierre University Hospital) ; Van Ranst, M. (AIDS Reference Laboratory. University Hospitals Leuven) ; Verhofstede, C. (AIDS Reference Laboratory. Department of Clinical Chemistry. Microbiology and Immunology. Ghent University) ; Stadler, T. (Swiss Institute of Bioinformatics) ; Lemey, P. (Laboratory of Clinical and Epidemiological Virology. Department of Microbiology and Immunology. Rega Institute for Medical Research. KU Leuven) ; Van Laethem, K. (AIDS Reference Laboratory. University Hospitals Leuven) ; Universitat Autònoma de Barcelona
Human immunodeficiency virus type 1 (HIV-1) non-B subtype infections occurred in Belgium since the 1980s, mainly amongst migrants and heterosexuals, whereas subtype B predominated in men-having-sex-with-men (MSM). [...]
2019 - 10.3389/fmicb.2019.00613
Frontiers in microbiology, Vol. 10 (march 2019) , p. 613  
10.
15 p, 6.6 MB Origin of the mobile di-hydro-pteroate synthase gene determining sulfonamide resistance in clinical isolates / Sánchez-Osuna, Miquel (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Cortés Garmendia, M. Pilar (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Barbé García, Jordi (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Erill Sagalés, Ivan (University of Maryland. Department of Biological Sciences (USA))
Sulfonamides are synthetic chemotherapeutic agents that work as competitive inhibitors of the di-hydro-pteroate synthase (DHPS) enzyme, encoded by the folP gene. Resistance to sulfonamides is widespread in the clinical setting and predominantly mediated by plasmid- and integron-borne sul1-3 genes encoding mutant DHPS enzymes that do not bind sulfonamides. [...]
2019 - 10.3389/fmicb.2018.03332
Frontiers in microbiology, Vol. 9 (January 2019) , art. 3332  

Dipòsit Digital de Documents de la UAB : 35 registres trobats   1 - 10següentfinal  anar al registre:
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.